Literature DB >> 25125234

[Acute on chronic respiratory failure in interstitial pneumonias].

M Westhoff1.   

Abstract

BACKGROUND: Acute exacerbations of idiopathic interstitial pneumonias and exacerbations of pleuropulmonary disease in connective tissue diseases are associated with a high mortality. DIAGNOSTIC PROCEDURES: They have to be differentiated from respiratory failure in patients with interstitial lung disease as a result of infections, pulmonary embolism, cardiac failure and drug toxicity, because the latter can be treated causally. The extent and the invasivity of diagnostic procedures have to be adopted to the patient's situation. A rapid diagnosis is important in order to initiate therapies (antibiotics, anticoagulation, immunosuppression) in treatable causes of exacerbations. IMPORTANCE OF VENTILATION: The prognosis for patients who are under invasive mechanical ventilation in acute exacerbations of interstitial lung disease is poor. Especially in acute exacerbations of idiopathic pulmonary fibrosis (IPF), there is no general recommendation for either invasive or for noninvasive ventilation. In acute exacerbations of other subtypes of interstitial pneumonia, either idiopathic or as a pulmonary manifestation of connective tissue disease, and in all secondary exacerbations of idiopathic interstitial pneumonias which offer further treatment options, the decision about mechanical ventilation requires a differentiated assessment. LUNG TRANSPLANTATION: In younger patients with interstitial lung disease and a progressive disease, indication for lung transplantation should be made early and before an exacerbation. If patients listed for lung transplantation experience an acute exacerbation, bridging-to-transplant has to be discussed with the transplant unit. In cases without further causal treatment options palliative care must be initiated.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25125234     DOI: 10.1007/s00063-014-0388-6

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  46 in total

1.  Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study.

Authors:  Marco Mura; Maria A Porretta; Elena Bargagli; Gianluigi Sergiacomi; Maurizio Zompatori; Nicola Sverzellati; Amedeo Taglieri; Fabrizio Mezzasalma; Paola Rottoli; Cesare Saltini; Paola Rogliani
Journal:  Eur Respir J       Date:  2012-01-12       Impact factor: 16.671

2.  Prognostic impact of high-flow nasal cannula oxygen supply in an ICU patient with pulmonary fibrosis complicated by acute respiratory failure.

Authors:  Alexandre Boyer; Frédéric Vargas; Maricke Delacre; Mélanie Saint-Léger; Benjamin Clouzeau; Gilles Hilbert; Didier Gruson
Journal:  Intensive Care Med       Date:  2010-09-18       Impact factor: 17.440

3.  Potential benefits of early continuous positive pressure ventilation in patients with rapidly progressive interstitial pneumonia.

Authors:  Toshiki Yokoyama; Kenji Tsushima; Hiroshi Yamamoto; Tomonobu Koizumi; Keishi Kubo
Journal:  Respirology       Date:  2012-02       Impact factor: 6.424

4.  Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.

Authors:  Ryo Tachikawa; Keisuke Tomii; Hiroyuki Ueda; Kazuma Nagata; Shigeki Nanjo; Ayako Sakurai; Kyoko Otsuka; Reiko Kaji; Michio Hayashi; Nobuyuki Katakami; Yukihiro Imai
Journal:  Respiration       Date:  2011-09-06       Impact factor: 3.580

5.  High-flow nasal cannula therapy in do-not-intubate patients with hypoxemic respiratory distress.

Authors:  Steve G Peters; Steven R Holets; Peter C Gay
Journal:  Respir Care       Date:  2013-04       Impact factor: 2.258

6.  Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction.

Authors:  Yasuyuki Kamata; Hiroyuki Nara; Takeshi Kamimura; Kengo Haneda; Masahiro Iwamoto; Junichi Masuyama; Hitoaki Okazaki; Seiji Minota
Journal:  Intern Med       Date:  2004-12       Impact factor: 1.271

Review 7.  Pulmonary pathology of the rheumatic diseases.

Authors:  Kevin O Leslie; Sylvain Trahan; James Gruden
Journal:  Semin Respir Crit Care Med       Date:  2007-08       Impact factor: 3.119

Review 8.  [Lung protective ventilation in ARDS].

Authors:  I Biener; M Czaplik; J Bickenbach; R Rossaint
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-08-22       Impact factor: 0.840

9.  Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis.

Authors:  Tomoo Kishaba; Hitoshi Tamaki; Yousuke Shimaoka; Hajime Fukuyama; Shin Yamashiro
Journal:  Lung       Date:  2013-11-13       Impact factor: 2.584

10.  A cohort study of mortality predictors and characteristics of patients with combined pulmonary fibrosis and emphysema.

Authors:  Tomoo Kishaba; Yousuke Shimaoka; Hajime Fukuyama; Kyoko Yoshida; Maki Tanaka; Shin Yamashiro; Hitoshi Tamaki
Journal:  BMJ Open       Date:  2012-05-15       Impact factor: 2.692

View more
  2 in total

1.  [In Process Citation].

Authors:  T Scheschkowski; S Budweiser
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-10-26       Impact factor: 0.840

2.  Visual vs Fully Automatic Histogram-Based Assessment of Idiopathic Pulmonary Fibrosis (IPF) Progression Using Sequential Multidetector Computed Tomography (MDCT).

Authors:  Davide Colombi; Julien Dinkel; Oliver Weinheimer; Berenike Obermayer; Teodora Buzan; Diana Nabers; Claudia Bauer; Ute Oltmanns; Karin Palmowski; Felix Herth; Hans Ulrich Kauczor; Nicola Sverzellati; Michael Kreuter; Claus Peter Heussel
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.